These results are consistent with prior studies in our lab that demonstrated hyper-acetylation of SIRT3 targets in cardiac-specific FXN KO hearts, including AceCS2, LCAD, and MCAD [31]. This evidence concerns the gene ACSS1 and medium chain acyl-CoA dehydrogenase deficiency.